Synopsis
Synopsis
0
EU WC
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Neomycin
2. Neomycin Palmitate
3. Neomycin Sulfate
1. Neomycin Sulfate
2. 1405-10-3
3. Neomycin Trisulfate Hydrate
4. Akos016010116
| Molecular Weight | 712.7 g/mol |
|---|---|
| Molecular Formula | C23H48N6O17S |
| Hydrogen Bond Donor Count | 15 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 9 |
| Exact Mass | 712.27966526 g/mol |
| Monoisotopic Mass | 712.27966526 g/mol |
| Topological Polar Surface Area | 436 Ų |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 953 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Neomycin sulfate |
| Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
| Active Ingredient | Neomycin sulfate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Oman Pharm Products; Teva; X Gen Pharms |
| 2 of 2 | |
|---|---|
| Drug Name | Neomycin sulfate |
| Drug Label | Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin which is an antibiotic obtained from the metabolic products of the actinomycete Streptomycesfradiae. Structurally, neomycin sulfate may be represented as follows:Chemically, i... |
| Active Ingredient | Neomycin sulfate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Oman Pharm Products; Teva; X Gen Pharms |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG ...DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
USFDA APPLICATION NUMBER - 50065
DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;E...DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50168
DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/G...DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50218
DOSAGE - SUSPENSION/DROPS;OTIC - EQ 3MG BASE/...DOSAGE - SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML
USFDA APPLICATION NUMBER - 50356
DOSAGE - OINTMENT;OPHTHALMIC - 400 UNITS/GM;E...DOSAGE - OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
USFDA APPLICATION NUMBER - 50417
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nippon Fine Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Solubilizers
Topical
Parenteral
Thickeners and Stabilizers
Controlled & Modified Release
Film Formers & Plasticizers
Direct Compression
Lubricants & Glidants
Emulsifying Agents
Granulation
Co-Processed Excipients
Surfactant & Foaming Agents
Taste Masking
API Stability Enhancers
Chewable & Orodispersible Aids
Empty Capsules
Vegetarian Capsules
Coloring Agents
Rheology Modifiers
Disintegrants & Superdisintegrants
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
69
PharmaCompass offers a list of Neomycin Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neomycin Sulfate manufacturer or Neomycin Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neomycin Sulfate manufacturer or Neomycin Sulfate supplier.
PharmaCompass also assists you with knowing the Neomycin Sulfate API Price utilized in the formulation of products. Neomycin Sulfate API Price is not always fixed or binding as the Neomycin Sulfate Price is obtained through a variety of data sources. The Neomycin Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NEOSPORIN G.U. IRRIGANT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NEOSPORIN G.U. IRRIGANT, including repackagers and relabelers. The FDA regulates NEOSPORIN G.U. IRRIGANT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NEOSPORIN G.U. IRRIGANT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NEOSPORIN G.U. IRRIGANT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NEOSPORIN G.U. IRRIGANT supplier is an individual or a company that provides NEOSPORIN G.U. IRRIGANT active pharmaceutical ingredient (API) or NEOSPORIN G.U. IRRIGANT finished formulations upon request. The NEOSPORIN G.U. IRRIGANT suppliers may include NEOSPORIN G.U. IRRIGANT API manufacturers, exporters, distributors and traders.
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NEOSPORIN G.U. IRRIGANT DMF (Drug Master File) is a document detailing the whole manufacturing process of NEOSPORIN G.U. IRRIGANT active pharmaceutical ingredient (API) in detail. Different forms of NEOSPORIN G.U. IRRIGANT DMFs exist exist since differing nations have different regulations, such as NEOSPORIN G.U. IRRIGANT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NEOSPORIN G.U. IRRIGANT DMF submitted to regulatory agencies in the US is known as a USDMF. NEOSPORIN G.U. IRRIGANT USDMF includes data on NEOSPORIN G.U. IRRIGANT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NEOSPORIN G.U. IRRIGANT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The NEOSPORIN G.U. IRRIGANT Drug Master File in Japan (NEOSPORIN G.U. IRRIGANT JDMF) empowers NEOSPORIN G.U. IRRIGANT API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the NEOSPORIN G.U. IRRIGANT JDMF during the approval evaluation for pharmaceutical products. At the time of NEOSPORIN G.U. IRRIGANT JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NEOSPORIN G.U. IRRIGANT Drug Master File in Korea (NEOSPORIN G.U. IRRIGANT KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NEOSPORIN G.U. IRRIGANT. The MFDS reviews the NEOSPORIN G.U. IRRIGANT KDMF as part of the drug registration process and uses the information provided in the NEOSPORIN G.U. IRRIGANT KDMF to evaluate the safety and efficacy of the drug.
After submitting a NEOSPORIN G.U. IRRIGANT KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NEOSPORIN G.U. IRRIGANT API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with KDMF on PharmaCompass.
A NEOSPORIN G.U. IRRIGANT CEP of the European Pharmacopoeia monograph is often referred to as a NEOSPORIN G.U. IRRIGANT Certificate of Suitability (COS). The purpose of a NEOSPORIN G.U. IRRIGANT CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of NEOSPORIN G.U. IRRIGANT EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of NEOSPORIN G.U. IRRIGANT to their clients by showing that a NEOSPORIN G.U. IRRIGANT CEP has been issued for it. The manufacturer submits a NEOSPORIN G.U. IRRIGANT CEP (COS) as part of the market authorization procedure, and it takes on the role of a NEOSPORIN G.U. IRRIGANT CEP holder for the record. Additionally, the data presented in the NEOSPORIN G.U. IRRIGANT CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the NEOSPORIN G.U. IRRIGANT DMF.
A NEOSPORIN G.U. IRRIGANT CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. NEOSPORIN G.U. IRRIGANT CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing NEOSPORIN G.U. IRRIGANT as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for NEOSPORIN G.U. IRRIGANT API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture NEOSPORIN G.U. IRRIGANT as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain NEOSPORIN G.U. IRRIGANT and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a NEOSPORIN G.U. IRRIGANT NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of NEOSPORIN G.U. IRRIGANT suppliers with NDC on PharmaCompass.
NEOSPORIN G.U. IRRIGANT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NEOSPORIN G.U. IRRIGANT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NEOSPORIN G.U. IRRIGANT GMP manufacturer or NEOSPORIN G.U. IRRIGANT GMP API supplier for your needs.
A NEOSPORIN G.U. IRRIGANT CoA (Certificate of Analysis) is a formal document that attests to NEOSPORIN G.U. IRRIGANT's compliance with NEOSPORIN G.U. IRRIGANT specifications and serves as a tool for batch-level quality control.
NEOSPORIN G.U. IRRIGANT CoA mostly includes findings from lab analyses of a specific batch. For each NEOSPORIN G.U. IRRIGANT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NEOSPORIN G.U. IRRIGANT may be tested according to a variety of international standards, such as European Pharmacopoeia (NEOSPORIN G.U. IRRIGANT EP), NEOSPORIN G.U. IRRIGANT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NEOSPORIN G.U. IRRIGANT USP).
